Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SIRUKUMAB vs SITAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SIRUKUMAB vs SITAGLIPTIN: Safety Overview

Metric SIRUKUMAB SITAGLIPTIN
Total FAERS Reports 1,345 19,904
Deaths Reported 847 2,412
Death Rate 63.0% 12.1%
Hospitalizations 812 6,668
Average Patient Age 43.2 yrs 67.3 yrs
% Female Patients 99.6% 52.3%
FDA Approval Date N/A Dec 30, 2025
Manufacturer N/A A-S Medication Solutions
Route N/A ORAL
Marketing Status N/A Prescription